BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 46 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,681 | -36.3% | 2,011 | -33.2% | 0.00% | – |
| Q4 2023 | $8,913 | -73.7% | 3,011 | -77.5% | 0.00% | – |
| Q3 2023 | $33,851 | -72.4% | 13,380 | -27.5% | 0.00% | – |
| Q2 2023 | $122,871 | -33.4% | 18,449 | +86.7% | 0.00% | – |
| Q1 2023 | $184,398 | -11.3% | 9,882 | +2.1% | 0.00% | – |
| Q4 2022 | $207,883 | +94.3% | 9,678 | +7.5% | 0.00% | – |
| Q3 2022 | $107,000 | -6.1% | 9,000 | +3.5% | 0.00% | – |
| Q2 2022 | $114,000 | -35.2% | 8,699 | +3.6% | 0.00% | – |
| Q1 2022 | $176,000 | +4.1% | 8,393 | +1.0% | 0.00% | – |
| Q4 2021 | $169,000 | -32.9% | 8,314 | 0.0% | 0.00% | – |
| Q3 2021 | $252,000 | +98.4% | 8,314 | +91.0% | 0.00% | – |
| Q2 2021 | $127,000 | -29.1% | 4,352 | +4.8% | 0.00% | – |
| Q1 2021 | $179,000 | -8.2% | 4,152 | -1.7% | 0.00% | – |
| Q4 2020 | $195,000 | +143.8% | 4,224 | +129.9% | 0.00% | – |
| Q3 2020 | $80,000 | -31.0% | 1,837 | -15.7% | 0.00% | – |
| Q2 2020 | $116,000 | +383.3% | 2,179 | +105.2% | 0.00% | – |
| Q1 2020 | $24,000 | +33.3% | 1,062 | -13.7% | 0.00% | – |
| Q4 2019 | $18,000 | +157.1% | 1,230 | +22.4% | 0.00% | – |
| Q3 2019 | $7,000 | -36.4% | 1,005 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | – | 1,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $7,040,000 | 3.41% |
| Ikarian Capital, LLC | 693,716 | $15,505,000 | 1.17% |
| EAM Global Investors LLC | 71,838 | $1,606,000 | 0.94% |
| Avidity Partners Management LP | 211,000 | $4,716,000 | 0.65% |
| MOODY ALDRICH PARTNERS LLC | 79,642 | $1,780,000 | 0.54% |
| Knoll Capital Management, LLC | 20,000 | $447,000 | 0.42% |
| EAM Investors, LLC | 55,775 | $1,247,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 299,932 | $6,703,000 | 0.22% |
| Coastal Bridge Advisors, LLC | 25,014 | $559,000 | 0.20% |
| Ikarian Capital, LLC | 103,300 | $2,309,000 | 0.17% |